News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Chiara Corti: Our ASCO Daily News editorial “IMpassion132”
Chiara Corti/LinkedIn
Aug 19, 2024, 06:51

Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti shared a post on LinkedIn:

“Check out our American Society of Clinical Oncology (ASCO) Daily News editorial ‘IMpassion132: Learning From Immunotherapy’s Failures in Early Relapsing Triple-Negative Breast Cancer’. ”

Source: Chiara Corti/LinkedIn

More posts by Chiara Corti in OncoDaily.

Chiara Corti is currently a Clinical Research Fellow at Dana-Farber Cancer Institute in Boston, focusing on early drug development for patients with solid tumors, with a special commitment to breast cancer. Since November 2019, she has also been a Medical Oncology Fellow at the European Institute of Oncology (IEO).

American Society of Clinical Oncology ASCO ASCO Daily News cancer Chiara Corti Dana-Farber Cancer Institute immunotherapy IMpassion132 OncoDaily Oncology triple-negative breast cancer
Special Coverage
Blog
Apr 26, 2025, 14:16
POEM's Fourth Scientific Meeting 2025: Key Sessions, Insights, and What Not to Miss
Blog
Apr 26, 2025, 13:55
Akshaya Keerti: I've always been a strong advocate of ADC shaping up the new treatment regimen and improving patient outcome
Blog
Apr 26, 2025, 13:26
Paolo Tarantino: Proud to be awarded a Conquer Cancer ASCO25 Merit Award
Blog
Apr 26, 2025, 13:21
Sami (Papacek) Mansfield: Why being a stress eater is a human behavior and what you can actually do about it
Blog
Apr 26, 2025, 13:18
Stephen Liu: Great discussions on antibody drug conjugates - including the future of ADCs in NSCLC
Blog
Apr 26, 2025, 13:13
Dipesh Uprety: SUPE_R Trial - CT vs. PET/CT Surveillance After Curative Treatment for Stage I-III NSCLC
Blog
Apr 26, 2025, 12:58
Thor Halfdanarson: It is not all about tumor shrinkage after PRRT
Blog
Apr 26, 2025, 12:53
Julie S. Torode: Applications are open for Early Career in Supportive Care Program
Blog
Apr 26, 2025, 12:47
Robin Zon: Honored to speak at Minnesota State Oncology Society Spring conference
Blog
Apr 26, 2025, 12:39
Charles Roberts: I am honored to be elected to the Board of Directors at AACR
Blog
Apr 26, 2025, 12:32
Fady Geara: Phase II Study of Upfront Immunotherapy with Radiation and TNT in MS-S Rectal Cancer
Blog
Apr 26, 2025, 12:23
Jarushka Naidoo: Honored to Serve as Track Chair for Developmental Therapeutics/Immunotherapy at ASCO